TFF Pharmaceuticals Inc (TFFP) Stock Price, Quote, News and Overview
NASDAQ:TFFP - Nasdaq - US87241J2033 - Common Stock - Currency: USD
TFFP Quote, Performance and Key Statistics
0.065
-0.1 (-60.05%)
The current stock price of TFFP is 0.065 USD. In the past month the price decreased by -96.13%. In the past year, price decreased by -99.17%.
TFFP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.53 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.62 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.81 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About TFFP
Company Profile
TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. The company is headquartered in Austin, Texas and currently employs 19 full-time employees. The company went IPO on 2019-10-25. The company is focused on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform. Its TFF technology platform has an applicability to convert any drug, including vaccines, small and large molecules, and biologics, into a dry powder for inhalation, or for topical delivery to the eyes, nose and the skin. TFF Pharmaceuticals has two lead drug candidates in the clinic: TFF TAC (Tacrolimus Inhalation Powder) and TFF VORI (Voriconazole Inhalation Powder). TFF TAC is an inhaled dry powder formulation of tacrolimus, for the prophylaxis of organ rejection in patients receiving lung transplants, in combination with other immunosuppressants. TFF VORI is an inhaled dry powder formulation of voriconazole, for the treatment and prophylaxis of invasive pulmonary aspergillosis.
Company Info
TFF Pharmaceuticals Inc
2600 Via Fortuna Ste 360
Austin TEXAS 78746 US
CEO: Glenn Mattes
Employees: 19
Company Website: https://tffpharma.com/
Investor Relations: https://ir.tffpharma.com/
Phone: 17378021973
TFF Pharmaceuticals Inc / TFFP FAQ
What is the stock price of TFF Pharmaceuticals Inc today?
The current stock price of TFFP is 0.065 USD. The price decreased by -60.05% in the last trading session.
What is the ticker symbol for TFF Pharmaceuticals Inc stock?
The exchange symbol of TFF Pharmaceuticals Inc is TFFP and it is listed on the Nasdaq exchange.
On which exchange is TFFP stock listed?
TFFP stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for TFF Pharmaceuticals Inc stock?
7 analysts have analysed TFFP and the average price target is 30.6 USD. This implies a price increase of 46976.92% is expected in the next year compared to the current price of 0.065. Check the TFF Pharmaceuticals Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is TFF Pharmaceuticals Inc worth?
TFF Pharmaceuticals Inc (TFFP) has a market capitalization of 288.60K USD. This makes TFFP a Nano Cap stock.
How many employees does TFF Pharmaceuticals Inc have?
TFF Pharmaceuticals Inc (TFFP) currently has 19 employees.
Is TFF Pharmaceuticals Inc (TFFP) expected to grow?
The Revenue of TFF Pharmaceuticals Inc (TFFP) is expected to grow by 60.13% in the next year. Check the estimates tab for more information on the TFFP EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy TFF Pharmaceuticals Inc (TFFP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TFFP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TFFP, evaluating the profitability, health, valuation and growth aspects
- TFF Pharmaceuticals Inc (TFFP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- TFF Pharmaceuticals Inc (TFFP) Sales and EPS estimates to see what analysts future expectations are.
- TFF Pharmaceuticals Inc (TFFP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- TFF Pharmaceuticals Inc (TFFP) Insider and Institutional Ownership to learn about the owners and their transactions.
- TFF Pharmaceuticals Inc (TFFP) Stock Chart to make your own analysis
- TFF Pharmaceuticals Inc (TFFP) Latest news and press-releases to stay up to date.
Does TFF Pharmaceuticals Inc (TFFP) stock pay dividends?
TFFP does not pay a dividend.
What is the Price/Earnings (PE) ratio of TFF Pharmaceuticals Inc (TFFP)?
TFF Pharmaceuticals Inc (TFFP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.44).
TFFP Technical Analysis
TFFP Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TFFP. While TFFP seems to be doing ok healthwise, there are quite some concerns on its profitability.
TFFP Financial Highlights
Over the last trailing twelve months TFFP reported a non-GAAP Earnings per Share(EPS) of -6.44. The EPS increased by 50.46% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -261.68% | ||
| ROE | -590.38% | ||
| Debt/Equity | 0 |
TFFP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to TFFP. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 65.1% and a revenue growth 60.13% for TFFP